Recombinant Factor VIIa in Acute Intracerebral Haemorrhage "FAST"
Completed
Phase 3 ResultsView Trial Locations
Recruitment
- Enrollment: 829
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 104 locations, 22 countries
Principal Investigator
- Nikolai C. Brun
Novo Nordisk
- Brett Skolnick, PhD
Novo Nordisk
- Global Clinical Registry (GCR, 1452)
Novo Nordisk A/S